Greenup Street Wealth Management LLC Purchases 9,144 Shares of Oracle Corporation $ORCL

Greenup Street Wealth Management LLC grew its position in Oracle Corporation (NYSE:ORCL) by 293.9% during the 1st quarter, HoldingsChannel reports. The fund owned 12,255 shares of the enterprise software provider’s stock after purchasing an additional 9,144 shares during the period. Greenup Street Wealth Management LLC’s holdings in Oracle were worth $1,803,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in ORCL. Perennial Investment Advisors LLC raised its position in Oracle by 0.5% in the 3rd quarter. Perennial Investment Advisors LLC now owns 9,627 shares of the enterprise software provider’s stock worth $2,708,000 after purchasing an additional 45 shares during the period. Consolidated Portfolio Review Corp lifted its stake in Oracle by 1.0% in the third quarter. Consolidated Portfolio Review Corp now owns 4,988 shares of the enterprise software provider’s stock worth $1,403,000 after purchasing an additional 50 shares during the last quarter. Mpwm Advisory Solutions LLC boosted its position in shares of Oracle by 76.9% during the third quarter. Mpwm Advisory Solutions LLC now owns 115 shares of the enterprise software provider’s stock valued at $32,000 after buying an additional 50 shares during the period. Clarion Wealth Managment Partners LLC boosted its position in shares of Oracle by 1.5% during the third quarter. Clarion Wealth Managment Partners LLC now owns 3,563 shares of the enterprise software provider’s stock valued at $1,002,000 after buying an additional 51 shares during the period. Finally, Verum Partners LLC grew its stake in shares of Oracle by 2.2% during the fourth quarter. Verum Partners LLC now owns 2,409 shares of the enterprise software provider’s stock valued at $470,000 after buying an additional 51 shares during the last quarter. Institutional investors own 42.44% of the company’s stock.

Oracle Stock Performance

Oracle stock opened at $157.38 on Thursday. The company has a debt-to-equity ratio of 3.21, a quick ratio of 1.35 and a current ratio of 1.12. The company has a market capitalization of $453.34 billion, a PE ratio of 27.00, a P/E/G ratio of 1.04 and a beta of 1.65. The company has a 50 day moving average price of $190.16 and a 200-day moving average price of $176.34. Oracle Corporation has a fifty-two week low of $134.57 and a fifty-two week high of $345.72.

Oracle (NYSE:ORCL) last announced its quarterly earnings data on Wednesday, June 10th. The enterprise software provider reported $2.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.96 by $0.15. The company had revenue of $19.18 billion for the quarter, compared to analysts’ expectations of $19.10 billion. Oracle had a return on equity of 58.62% and a net margin of 25.37%.Oracle’s revenue was up 20.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.70 earnings per share. Oracle has set its Q1 2027 guidance at 1.720-1.760 EPS and its FY 2027 guidance at 8.050-8.050 EPS. As a group, equities analysts forecast that Oracle Corporation will post 6.45 earnings per share for the current year.

Oracle Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 24th. Stockholders of record on Friday, July 10th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, July 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.3%. Oracle’s dividend payout ratio is presently 34.31%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on ORCL shares. TD Cowen increased their price target on Oracle from $250.00 to $300.00 and gave the stock a “buy” rating in a report on Monday, June 8th. Sanford C. Bernstein boosted their price objective on Oracle from $319.00 to $325.00 and gave the company an “outperform” rating in a report on Thursday, June 11th. Mizuho set a $320.00 price objective on Oracle in a research report on Wednesday, June 3rd. BTIG Research reiterated a “buy” rating and issued a $400.00 target price on shares of Oracle in a research note on Friday, June 5th. Finally, Scotiabank reiterated an “overweight” rating on shares of Oracle in a research report on Thursday, June 11th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $268.27.

Key Oracle News

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle is still being viewed by some analysts as a major AI infrastructure winner, with commentary pointing to a massive AI backlog that could convert into revenue over the next several years. Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
• Positive Sentiment: Oracle Health announced an AI collaboration with Theator to extend AI into operating rooms, which could support future growth in healthcare workflows, documentation, and billing automation. Oracle Health Extends AI into the Operating Room in Collaboration with Theator
• Neutral Sentiment: Several bullish articles argue Oracle’s recent sell-off may be overdone and that the stock could rebound if backlog conversion and cloud growth continue to improve investor confidence. Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
• Neutral Sentiment: Oracle’s annual filing and follow-up coverage confirmed the workforce reductions were tied to broader AI adoption, but the company framed them as part of a restructuring effort rather than a sign of operational distress. Oracle Sheds 21,000 Jobs as It Continues AI-Focused Streamlining
• Negative Sentiment: Investors are worried that Oracle’s AI spending is being funded with more debt and that preferred stock conversions or ATM share issuance could dilute shareholders and weigh on the stock price. Oracle Analyst Warns: Preferred Stock Conversions and ATM Issuances May Dilute Shareholders and Pressure Stock Price
• Negative Sentiment: Broader tech weakness and an AI sector pullback are also adding to ORCL’s decline, as investors reassess high-spending AI names. Sector Update: Tech Stocks Fall Late Afternoon

Insider Activity

In other news, EVP Stuart Levey sold 15,000 shares of the firm’s stock in a transaction on Thursday, April 16th. The stock was sold at an average price of $176.19, for a total transaction of $2,642,850.00. Following the transaction, the executive vice president owned 3,429 shares in the company, valued at approximately $604,155.51. This trade represents a 81.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 40.90% of the company’s stock.

Oracle Profile

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle’s product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.